Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.87 -3.77%
EPS Growth %: -30.4%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -30.4%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $45.27 million versus the consensus estimate of $37 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- United Community Banks sells equipment finance unit for $1.9 billion
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
